Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection

NACompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

August 20, 2021

Study Completion Date

August 20, 2021

Conditions
Breast Cancer
Interventions
DEVICE

Clinical investigation device class IIa not marked CE

Patients should perform MammoWave exam. A short visit should be performed and during this visit a qualitative differentiation would be performed between patients with high density breast, and patients with low density breast. After the patients will be ready for the MammoWave exam. The exam will be composed of two phases: the data acquisition and the data processing. During the acquisition that should takes about 10 minutes the patients would be lying in a prone position, on a bed which is part of the MammoWave. The upper part of MammoWave has a container cup shape, which contains the breast, which also has the function of separate it from the internal parts of the device. After patient is on the bed and MammoWave would start to perform the acquisition. Once the acquisition is completed, the data will be processed through an imaging algorithm, which is integrated in the device. The final output will be composed by one or more images, plus one or more parameters describing the images.

Trial Locations (3)

16132

Azienda Ospedaliera Universitaria S. Martino Di Genova, Genova

Hospital Virgen de la Salud, Toledo

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Umbria Bioengineering Technologies

INDUSTRY

NCT04253366 - Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection | Biotech Hunter | Biotech Hunter